Bio­gen’s no good week; In­side gene edit­ing's open se­cret; No­vo Nordisk ab­sorbs RNAi part­ner; Boost­ers for all; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We are wrap­ping up this year’s spe­cial re­port on 20 trail­blaz­ing women in bio­phar­ma R&D, and can’t be more ex­cit­ed to share their sto­ries on De­cem­ber 7, both through the writ­ten pro­files and a live event, fol­lowed by a pan­el on gen­der is­sues mod­er­at­ed by Nicole De­Feud­is and my­self. Learn more and sign up here.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.